Atrial Fibrillation: WOEST-3 Study

We are exploring a new antithrombotic strategy for patients with atrial fibrillation undergoing heart procedures. The goal is to see if this approach reduces bleeding and heart-related risks compared to standard treatment.

1-2 yearsMonitoring phase (IV)No PlaceboCost ReimbursementStandard MedicinesOralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Aspirin
Aspirin is a medicine used to relieve pain, reduce fever, and lower the chance of heart attacks or strokes.
Clopidogrel Viatris
Clopidogrel Viatris is a medicine that helps prevent harmful blood clots to reduce the risk of heart attack and stroke.
Edoxaban
Edoxaban is a medicine that thins the blood to help prevent strokes in people with irregular heartbeat and treat or prevent harmful blood clots.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Acetylsalicylic Acid
Acetylsalicylic acid is a substance that reduces pain, fever, and inflammation and can help prevent blood clots.
Acetylsalicylic Acid Ph. Eur.
Acetylsalicylic acid is a substance that relieves pain, reduces fever, and helps prevent blood clots.
Clopidogrel
Clopidogrel is a substance that helps prevent blood clots by stopping platelets from sticking together, lowering the risk of heart attack and stroke.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aas
Abrea
Acard

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Algemeen Stedelijk Ziekenhuis Campus Aalst
Cardiology
Aalst, Belgium
UZ Brussel
Cardiology
Ganshoren, Belgium
Ziekenhuis Oost Limburg
Cardiology
Genk, Belgium
Sponsor: St Antonius Hospital
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.